Home › Funds › APIS CAPITAL ADVISORS, LLC › TVTX

APIS CAPITAL ADVISORS, LLC position in TVTX

TRAVERE THERAPEUTICS INC · Health Care

APIS CAPITAL ADVISORS, LLC reported holding 158,000 shares of TVTX (TRAVERE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$9.3M, representing 1.31% of its reported portfolio and ranking #27 among its reported holdings. APIS CAPITAL ADVISORS, LLC has disclosed TVTX holdings in 4 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)158.00K sh
Reported value held$9.30M
Portfolio Weight1.31%
First reportedQ3 2025
Last changeAdd
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How APIS CAPITAL ADVISORS, LLC's TVTX position evolved

APIS CAPITAL ADVISORS, LLC first disclosed a stake in TVTX in Q3 2025 at 166,000 shares (US$4.0M). The position peaked in Q3 2026 at 158,000 shares, worth US$9.3M. Across 4 filings, APIS CAPITAL ADVISORS, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 158,000 shares valued at US$9.3M — an increase of 46,000 shares quarter over quarter.. Notable position changes include a 41% increase in Q3 2026 (shares fell 14% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 166.00K $3.97M New
Q4 2025 186.00K $7.11M Add
Q2 2026 112.00K $6.36M New
Q3 2026 158.00K $9.30M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TVTX and 13F data

TVTX (TRAVERE THERAPEUTICS INC) is a Health Care company. 57 other funds we track also report a position in TVTX — the largest reported positions include PERCEPTIVE ADVISORS LLC (US$213.2M), Rock Springs Capital Management LP (US$123.8M), Kynam Capital Management, LP (US$113.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TVTX

All TVTX fund holders →

FAQ

How long has APIS CAPITAL ADVISORS, LLC held TVTX?

APIS CAPITAL ADVISORS, LLC has disclosed TVTX holdings in 4 of the last 5 reported quarters, going back to Q3 2025.

What is APIS CAPITAL ADVISORS, LLC's current position in TVTX?

As of Q3 2026, APIS CAPITAL ADVISORS, LLC holds 158.00K shares of TVTX (TRAVERE THERAPEUTICS INC), valued at $9.30M, representing 1.31% of its reported portfolio and ranking #27.

Has APIS CAPITAL ADVISORS, LLC been buying or selling TVTX?

In the latest 13F filing (Q3 2026), APIS CAPITAL ADVISORS, LLC increased its position in TVTX. The position peaked in Q3 2026 at 158.00K shares.

Which other funds hold TVTX?

Other major institutional holders of TVTX include PERCEPTIVE ADVISORS LLC, Rock Springs Capital Management LP, Kynam Capital Management, LP, among 57 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.